Literature DB >> 7540839

Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells.

S Jimi1, K Ito, K Kohno, M Ono, M Kuwano, Y Itagaki, H Ishikawa.   

Abstract

Angiogenin is a potent angiogenic molecule in the chick chorioallantoic membrane assay and rabbit corneal assay. However, no angiogenic activity has been reported in in vitro system. In this study, we isolated and purified angiogenin from bovine milk, and the biological effect of the bovine angiogenin on bovine endothelial cells was examined in in vitro angiogenesis models. Bovine angiogenin significantly stimulated both cell migration and formation of tube-like structures in the collagen gel by bovine aortic endothelial cells. Angiogenin at 10-100 ng/ml stimulated about 2-fold higher the tube formation when basic fibroblast growth factor (bFGF) at 10 ng/ml stimulated about 3-fold over the control. Tubular morphogenesis stimulated by bFGF or angiogenin was almost completely blocked in the presence of aprotinin, an inhibitor of serine proteases. Angiogenin up-regulated both mRNA level and activity of urokinase type plasminogen activator, a key mediator of angiogenesis. Moreover, both bFGF and bovine angiogenin induced a marked increase of c-fos mRNA level at 30 min after stimulation. These novel effects of bovine angiogenin are to be discussed in relation to its structure specificity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540839     DOI: 10.1006/bbrc.1995.1838

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Molecular recognition of human angiogenin by placental ribonuclease inhibitor--an X-ray crystallographic study at 2.0 A resolution.

Authors:  A C Papageorgiou; R Shapiro; K R Acharya
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

Review 2.  New insights into the role of angiogenin in actin polymerization.

Authors:  Mikhail G Pyatibratov; Alla S Kostyukova
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

3.  Angiogenin in sera as an independent prognostic factor in gastric cancer.

Authors:  Shouji Shimoyama; Michio Kaminishi
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-08       Impact factor: 4.553

4.  Adipose-derived mesenchymal stromal cells from aged patients with coronary artery disease keep mesenchymal stromal cell properties but exhibit characteristics of aging and have impaired angiogenic potential.

Authors:  Anastasia Efimenko; Nina Dzhoyashvili; Natalia Kalinina; Tatiana Kochegura; Renat Akchurin; Vsevolod Tkachuk; Yelena Parfyonova
Journal:  Stem Cells Transl Med       Date:  2013-12-18       Impact factor: 6.940

Review 5.  Angiogenin-mediated ribosomal RNA transcription as a molecular target for treatment of head and neck squamous cell carcinoma.

Authors:  Lili Chen; Guo-fu Hu
Journal:  Oral Oncol       Date:  2010-07-24       Impact factor: 5.337

6.  rAAV-mediated angiogenin gene transfer induces angiogenesis and modifies left ventricular remodeling in rats with myocardial infarction.

Authors:  Xiao-Yan Zhao; Shen-Jiang Hu; Jiang Li; Yun Mou; Chi-Fung Chan; Juan Jin; Jian Sun; Zhao-Hui Zhu
Journal:  J Mol Med (Berl)       Date:  2006-09-06       Impact factor: 4.599

7.  Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease.

Authors:  F Magro; F Araujo; P Pereira; E Meireles; M Diniz-Ribeiro; F Tavarela Velosom
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

8.  Neomycin inhibits angiogenin-induced angiogenesis.

Authors:  G F Hu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

9.  Ribonuclease inhibitor regulates neovascularization by human angiogenin.

Authors:  Kimberly A Dickson; Dong-Ku Kang; Young Sam Kwon; Jae Chan Kim; Peter A Leland; Byung-Moon Kim; Soo-Ik Chang; Ronald T Raines
Journal:  Biochemistry       Date:  2009-05-12       Impact factor: 3.162

Review 10.  Antiangiogenic therapy in brain tumors.

Authors:  Sajani S Lakka; Jasti S Rao
Journal:  Expert Rev Neurother       Date:  2008-10       Impact factor: 4.618

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.